Post-effective amendment to a registration statement that is not immediately effective upon filing

Revisions of Previously Issued Financial Statements (Tables)

v3.20.4
Revisions of Previously Issued Financial Statements (Tables)
3 Months Ended 12 Months Ended
Sep. 30, 2020
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Schedule of financial statements
  Three Months Ended September 30, 2019  
    As reported     Adjustment     As revised  
Condensed Consolidated Statements of Operations                  
Cost of revenue   $ 1,397,361     $ (17,660 )   $ 1,379,701  
Gross profit     1,795,529       17,660       1,813,189  
Product development     1,130,880       (519,978 )     610,902  
Selling, general and administrative     3,583,815       17,899       3,601,714  
Net loss     (2,846,071 )     519,739       (2,326,332 )
Net loss per share     (0.26 )           (0.21 )
                         
    Three Months Ended December 31, 2019  
    As reported     Adjustment     As revised  
Condensed Consolidated Statements of Operations                  
Cost of revenue   $ 1,638,840     $ (23,601 )   $ 1,615,239  
Gross profit     1,667,363       23,601       1,690,964  
Product development     1,261,509       (638,008 )     623,501  
Selling, general and administrative     4,796,404       86,768       4,883,172  
Net loss     (4,338,536 )     574,841       (3,763,695 )
Net loss per share     (0.40 )           (0.34 )
                         
    Six Months Ended December 31, 2019  
    As reported     Adjustment     As revised  
Condensed Consolidated Statements of Operations                  
Cost of revenue   $ 3,036,201     $ (41,261 )   $ 2,994,940  
Gross profit     3,462,892       41,261       3,504,153  
Product development     2,392,389       (1,157,986 )     1,234,403  
Selling, general and administrative     8,380,219       104,667       8,484,886  
Net loss     (7,184,607 )     1,094,580       (6,090,027 )
Net loss per share     (0.66 )           (0.56 )
                         
    Three Months Ended March 31, 2020  
    As reported     Adjustment     As revised  
Condensed Consolidated Statement of Operations                  
Cost of revenue   $ 1,420,909     $ (24,690 )   $ 1,396,219  
Gross profit     1,649,637       24,690       1,674,327  
Product development     1,632,353       (757,566 )     874,787  
Selling, general and administrative     5,500,837       177,405       5,678,242  
Net loss     (5,348,980 )     604,851       (4,744,129 )
Net loss per share     (0.43 )           (0.38 )
                         
    Nine Months Ended March 31, 2020  
    As reported     Adjustment     As revised  
Condensed Consolidated Statements of Operations                  
Cost of revenue   $ 4,457,110     $ (65,951 )   $ 4,391,159  
Gross profit     5,112,529       65,951       5,178,480  
Product development     4,024,742       (1,915,552 )     2,109,190  
Selling, general and administrative     13,881,056       282,072       14,163,128  
Net loss     (12,533,587 )     1,699,431       (10,834,156 )
Net loss per share     (1.11 )           (0.96 )

    Three Months Ended
September 30, 2019
 
    As reported     Adjustment     As revised  
Condensed Consolidated Statements of Operations                  
Cost of revenue   $ 1,397,361     $ (17,660 )   $ 1,379,701  
Gross profit     1,795,529       17,660       1,813,189  
Product development     1,130,880       (519,978 )     610,902  
Selling, general and administrative     3,583,815       17,899       3,601,714  
Net loss     (2,846,071 )     519,739       (2,326,332 )
Net loss per share     (0.26 )             (0.21 )

 

    Three Months Ended
December 31, 2019
 
    As reported     Adjustment     As revised  
Condensed Consolidated Statements of Operations                  
Cost of revenue     1,638,840       (23,601 )     1,615,239  
Gross profit     1,667,363       23,601       1,690,964  
Product development     1,261,509       (638,008 )     623,501  
Selling, general and administrative     4,796,404       86,768       4,883,172  
Net loss     (4,338,536 )     574,841       (3,763,695 )
Net loss per share     (0.40 )             (0.34 )

 

    Six Months Ended
December 31, 2019
 
    As reported   Adjustment   As revised  
Condensed Consolidated Statements of Operations                    
Cost of revenue     3,036,201     (41,261)     2,994,940  
Gross profit     3,462,892     41,261     3,504,153  
Product development     2,392,389     (1,157,986)     1,234,403  
Selling, general and administrative     8,380,219     104,667     8,484,886  
Net loss     (7,184,607 )   1,094,580     (6,090,027 )
Net loss per share     (0.66 )         (0.56 )

 

    Three Months Ended
March 31, 2020
 
    As reported     Adjustment     As revised  
Condensed Consolidated Statement of Operations                  
Cost of revenue     1,420,909       (24,690 )     1,396,219  
Gross profit     1,649,637       24,690       1,674,327  
Product development     1,632,353       (757,566 )     874,787  
Selling, general and administrative     5,500,837       177,405       5,678,242  
Net loss     (5,348,980 )     604,851       (4,744,129 )
Net loss per share     (0.43 )             (0.38 )

 

    Nine Months Ended
March 31, 2020
 
    As reported     Adjustment     As revised  
Condensed Consolidated Statements of Operations                  
Cost of revenue     4,457,110       (65,951 )     4,391,159  
Gross profit     5,112,529       65,951       5,178,480  
Product development     4,024,742       (1,915,552 )     2,109,190  
Selling, general and administrative     13,881,056       282,072       14,163,128  
Net loss     (12,533,587 )     1,699,431       (10,834,156 )
Net loss per share     (1.11 )             (0.96 )